Login

Diamyd Medical | interview with CEO Ulf Hannelius 00:00:00

Share On Facebook Share On Twitter

Diamyd Medical | interview with CEO Ulf Hannelius

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Ultra Lithium Reports Promising Drill Results and Eyes Strategic Partnerships
00:10:00
NeoLithium Explores High-Grade, Low-Impurity Lithium Projects in Argentina
00:10:00
Aeris Resources: Transforming with Strong Copper Production and Exploration Focus
00:10:00
Rick Rule on Financial Resilience and Market Insights Amidst Uncertainty
00:10:00
Robex Resources Inc. CEO Aurélien Bonneviot discusses company assets, including the Napala mine in Mali, during Deutsche Goldmesse Day 1 in Frankfurt.|Aurélien Bonneviot CEO of Robex Resources Inc.
00:10:00
Explore the New Features of Your Morningstar Web Portal
00:10:00
Christoph Vilanek is the CEO of Freenet.
00:10:00
Patriot Lithium CEO Nicholas Vickery Discusses High-Grade Spodumene Prospects | Nick Vickery ,CEO , Patriot Lithium Ltd.
00:10:00
Teleborsa S.p.A. interviews Alessio Aceti, CEO of Sababa Security.
00:00:00
Ergomed in robust shape to keep delivering - Jonathan Curtain, CFO, Ergomed
00:10:00
advangeo® - Geospatial Prediction with Artificial Neural Networks and GIS - Released by Beak Consultants GmbH | ANDREAS KNOBLOCH, Managing Director, Beak Consultants GmbH (TS)
00:10:00
ADLINK CEO Jim Liu explains the company’s evolution from Embedded to Edge at Embedded World 2020 | Jim Liu, CEO, ADLINK Technology Inc6166:TAI

© 2026 Nehu